Daniel J. Adams

550 total citations
15 papers, 394 citations indexed

About

Daniel J. Adams is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Daniel J. Adams has authored 15 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in Daniel J. Adams's work include Influenza Virus Research Studies (2 papers), Lipid Membrane Structure and Behavior (2 papers) and Tuberculosis Research and Epidemiology (1 paper). Daniel J. Adams is often cited by papers focused on Influenza Virus Research Studies (2 papers), Lipid Membrane Structure and Behavior (2 papers) and Tuberculosis Research and Epidemiology (1 paper). Daniel J. Adams collaborates with scholars based in United States, United Kingdom and Singapore. Daniel J. Adams's co-authors include Michael H. B. Stowell, Christopher P. Arthur, Joseph Schlessinger, Francisco Tomé, Carmen J. Booth, Irit Lax, Veraragavan P. Eswarakumar, Jae Hyun Bae, Erin D. Lew and Gergely Kiss and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and PLoS ONE.

In The Last Decade

Daniel J. Adams

13 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel J. Adams United States 8 217 110 77 48 46 15 394
Sandra Dollet France 8 155 0.7× 48 0.4× 56 0.7× 58 1.2× 37 0.8× 13 453
Yi Geng United States 11 272 1.3× 72 0.7× 88 1.1× 44 0.9× 13 0.3× 17 541
Roland Csépányi‐Kömi Hungary 10 314 1.4× 244 2.2× 29 0.4× 36 0.8× 41 0.9× 20 588
Víctor Barrera United States 13 220 1.0× 240 2.2× 57 0.7× 20 0.4× 30 0.7× 25 560
Roxana Kariminejad Iran 13 231 1.1× 70 0.6× 258 3.4× 25 0.5× 31 0.7× 40 683
Carl A. Mitchell United States 8 282 1.3× 178 1.6× 61 0.8× 26 0.5× 24 0.5× 9 521
Kai‐Hsin Chang United States 13 262 1.2× 111 1.0× 64 0.8× 12 0.3× 61 1.3× 15 540
Wen-Wei Tsai United States 9 480 2.2× 99 0.9× 43 0.6× 35 0.7× 28 0.6× 9 625
Wenguang Yin China 11 185 0.9× 25 0.2× 53 0.7× 42 0.9× 45 1.0× 20 336
Isabelle Rouvet France 11 250 1.2× 73 0.7× 27 0.4× 65 1.4× 34 0.7× 13 371

Countries citing papers authored by Daniel J. Adams

Since Specialization
Citations

This map shows the geographic impact of Daniel J. Adams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Adams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Adams more than expected).

Fields of papers citing papers by Daniel J. Adams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. Adams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Adams. The network helps show where Daniel J. Adams may publish in the future.

Co-authorship network of co-authors of Daniel J. Adams

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. Adams. A scholar is included among the top collaborators of Daniel J. Adams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. Adams. Daniel J. Adams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wyman, Bradley T., Daniel J. Adams, Suzanne Hendrix, et al.. (2025). A double-blind, controlled trial of circadian effective light therapy in patients with Parkinson's disease. Neurotherapeutics. 22(6). e00728–e00728.
2.
Wang, Chuchu, Wenhong Jiang, Jeremy Leitz, et al.. (2024). Structure and topography of the synaptic V-ATPase–synaptophysin complex. Nature. 631(8022). 899–904. 23 indexed citations
3.
Luther, Jay, Sanjoy K. Khan, Manish Gala, et al.. (2020). Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation. Proceedings of the National Academy of Sciences. 117(21). 11667–11673. 69 indexed citations
4.
Humphreys, Sara C., et al.. (2020). Emerging siRNA Design Principles and Consequences for Biotransformation and Disposition in Drug Development. Journal of Medicinal Chemistry. 63(12). 6407–6422. 20 indexed citations
5.
Adams, Daniel J., Travis Nemkov, John P. Mayer, William M. Old, & Michael H. B. Stowell. (2017). Identification of the primary peptide contaminant that inhibits fibrillation and toxicity in synthetic amyloid-β42. PLoS ONE. 12(8). e0182804–e0182804. 9 indexed citations
6.
Deiteren, Annemie, João Paulo Castro, Tracey A. O’Donnell, et al.. (2016). Modulation of colonic sensory signaling by novel alpha-conotoxin Vc1.1 analogues in mice. Queensland's institutional digital repository (The University of Queensland). 6 indexed citations
7.
Adams, Daniel J., et al.. (2016). Prevalence of vector-borne diseases in a sample of client-owned dogs on Santa Cruz in the Galápagos Islands: A pilot study. Veterinary Parasitology Regional Studies and Reports. 6. 28–30. 6 indexed citations
9.
Adams, Daniel J., Christopher P. Arthur, & Michael H. B. Stowell. (2015). Architecture of the Synaptophysin/Synaptobrevin Complex: Structural Evidence for an Entropic Clustering Function at the Synapse. Scientific Reports. 5(1). 13659–13659. 47 indexed citations
10.
Németh, Beáta, Judit Dóczi, Daniel J. Adams, et al.. (2015). Abolition of mitochondrial substrate‐level phosphorylation by itaconic acid produced by LPS‐induced Irg1 expression in cells of murine macrophage lineage. The FASEB Journal. 30(1). 286–300. 109 indexed citations
11.
Adams, Daniel J., et al.. (2014). A Catheter-related Bloodstream Infection With Mycobacterium frederiksbergense in an Immunocompromised Child. The Pediatric Infectious Disease Journal. 34(4). 445–447. 5 indexed citations
12.
Izikson, Ruvim, et al.. (2013). Safety and Immunogenicity of Flublok®, a Highly Purified Recombinant Recombinant Influenza Vaccine Made without Eggs or Live Influenza Viruses. Journal of Allergy and Clinical Immunology. 131(2). AB11–AB11. 1 indexed citations
13.
Adams, Daniel J., et al.. (2012). An Unusual Presentation of Inflammatory Bowel Disease. Military Medicine. 177(2). 240–242. 2 indexed citations
14.
Adams, Daniel J., et al.. (2006). Client perceptions of the MUSCSEL project: a community‐based physical activity programme for patients with mental health problems. Journal of Public Mental Health. 5(4). 45–52. 11 indexed citations
15.
Eswarakumar, Veraragavan P., Erin D. Lew, Jae Hyun Bae, et al.. (2006). Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis. Proceedings of the National Academy of Sciences. 103(49). 18603–18608. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026